Literature DB >> 19839639

Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.

Elda Favari1, Laura Calabresi, Maria Pia Adorni, Wendy Jessup, Sara Simonelli, Guido Franceschini, Franco Bernini.   

Abstract

The aim of this study was to correlate the lipid content and size of discoidal reconstituted HDL particles with their ability to promote cellular cholesterol efflux. Homogeneous discoidal rHDL particles containing apoA-I and POPC, with diameters of 7.8, 9.6, 10.8, 12.5, and 17.0 nm, were prepared by the cholate dialysis technique. Cholesterol efflux to rHDL was evaluated in pathway-specific cell models for ABCA1-, ABCG1-, and SR-BI-mediated efflux. ABCA1-mediated efflux was efficiently promoted by the 7.8 nm rHDL containing 82 POPC molecules per particle. This rHDL also promoted ABCG1, but not SR-BI, cholesterol efflux. All large and lipid-rich rHDLs, with a diameter of >or=9.6 nm and a phospholipid content of >/=202 molecules per particle, promoted both SR-BI- and ABCG1-mediated efflux. Our results indicated that the ABCA1-mediated cell cholesterol efflux can be efficiently driven not only by monomolecular lipid free/poor apoA-I but also by a small discoidal phospholipid-containing particle resembling plasma pre-beta1 HDL. This same particle also promotes ABCG1- but not SR-BI-mediated efflux. These results help to clarify the role of plasma pre-beta1 HDL in reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839639     DOI: 10.1021/bi901564g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

Review 2.  Cardioprotective functions of HDLs.

Authors:  Kerry-Anne Rye; Philip J Barter
Journal:  J Lipid Res       Date:  2013-06-27       Impact factor: 5.922

Review 3.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

Review 4.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

Review 5.  Update on HDL receptors and cellular cholesterol transport.

Authors:  Ginny Kellner-Weibel; Margarita de la Llera-Moya
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

6.  ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects.

Authors:  Elda Favari; Nicoletta Ronda; Maria Pia Adorni; Francesca Zimetti; Paolo Salvi; Matteo Manfredini; Franco Bernini; Claudio Borghi; Arrigo F G Cicero
Journal:  J Lipid Res       Date:  2012-10-28       Impact factor: 5.922

7.  Scavenger receptor SR-BI in macrophage lipid metabolism.

Authors:  Ailing Ji; Jason M Meyer; Lei Cai; Akinwunmi Akinmusire; Maria C de Beer; Nancy R Webb; Deneys R van der Westhuyzen
Journal:  Atherosclerosis       Date:  2011-04-09       Impact factor: 5.162

8.  Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians.

Authors:  Francesca Zimetti; Wladimir M Freitas; Alessandra M Campos; Mauricio Daher; Maria Pia Adorni; Franco Bernini; Andrei C Sposito; Ilaria Zanotti
Journal:  J Lipid Res       Date:  2018-02-07       Impact factor: 5.922

9.  Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.

Authors:  Jie Tang; Dan Li; Lindsey Drake; Wenmin Yuan; Sara Deschaine; Emily E Morin; Rose Ackermann; Karl Olsen; David E Smith; Anna Schwendeman
Journal:  J Lipid Res       Date:  2016-11-23       Impact factor: 5.922

10.  Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Maciej Banach; Magdalena Rysz-Górzyńska
Journal:  Int Urol Nephrol       Date:  2016-12-09       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.